fda compounding semaglutide news september 2025 Drug Recalls and Warnings: Recalls for Compounded and Tirzepatide, Wegovy; Facility Warning Letters GLP-1 weight loss drugs are

The exhausted employee's brain can't handle healthy habits, even when they know better

By regulating appetite, boosting metabolism, and stabilizing blood sugar, GLP-1s could play a key role in easing some challenges of menopause

Discover the potential benefits of CJC-1295 DAC synthetic peptide, how it can enhance pulsatile growth hormone secretion, metabolic processes, and energy expenditure

Two decades of clinical use, multiple cardiovascular outcome trials, and a growing list of approved indications now sit behind these molecules

Cloning and characterization of a putative Ca2+/H+ antiporter gene from Escherichia coli upon functional complementation of Na+/H+ antiporter-deficient strains by the overexpressed gene

The FDA encourages patients and prescribers to report adverse events or quality issues linked to compounded semaglutide to the MedWatch Adverse Event Reporting Program